4//SEC Filing
Semigran Marc 4
Accession 0001562180-23-000045
CIK 0001710072other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:44 PM ET
Size
5.5 KB
Accession
0001562180-23-000045
Insider Transaction Report
Form 4
Semigran Marc
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-30+300,000→ 300,000 totalExercise: $8.94Exp: 2032-12-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option become vested and exercisable on December 19, 2023 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date.
Documents
Issuer
Edgewise Therapeutics, Inc.
CIK 0001710072
Entity typeother
Related Parties
1- filerCIK 0001691494
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:44 PM ET
- Size
- 5.5 KB